How to improve care and drive productivity in health providers. What works today? What will work in five years time? Presented at the Healthcare Europa Annual Conference 2014, The Return of the Bull Market.
Who would ever feel sorry for big reagent manufacturers - Abbott, Roche and Siemens? Well, from what we hear, the big lab groups really are squeezing them dry.
The vast majority of bribes paid by citizens in Europe have to do with access to healthcare, according to an EU anti-corruption report. Healthcare and pharma businesses in Europe are also the most likely of any industry, with 77% agreeing, to think that corruption is widespread in their country. The report puts the total cost of corruption in the EU at €120bn - a little less than the annual EU budget. We look at the underlying numbers.
Hungarian sources say that recent healthcare reform, pushed through by Minister of State for health, Dr. Miklós Szócska, under the Fidesz government, has succeeded in cutting costs substantially. Nonetheless, the government has upped healthcare expenditure ahead of elections in 2014.
Telki Privatklinik, the first and only private hospital in the Budapest region, has announced that it will close. The 100-bed hospital has claimed that Hungarian law changes legalising ‘envelope payments’ – informal payments to public-sector doctors for better and faster treatment – have essentially turned the public sector into a subsidised competitor to the private sector. But is the government to blame for Telki’s woes?
UPS has recently bought CEMELOG, a Budapest-based logistics hub specialising in medtech and pharma. We talk to Daniel Gagnon, Director of Healthcare Logistics & Strategy for UPS Europe, about the company’s strategy and the impact on distribution and healthcare services.
How are players dependent on a shrinking public purse in South and East Europe reacting? Who better to ask than Dimitris Moulavasilis, CEO of Euromedic? The company offers imaging, labs and oncology services in 15 countries, from Ireland and Portugal in the West to Russia and Turkey in the East.
What are the prospects for investors over the next five years? And what do the numbers tell us about the sector’s recovery? Henrichs looks in-depth at recent valuations, M&A and financing activity. Presented at the Healthcare Europa Annual Conference 2013, New Models for Challenging Times.
Nicolaus has unrivaled access to, and experience
of, European payors. He examines the reform
trajectory and likely budget growth in different
European countries and considers what impact this will have for private hospitals, outsourcers and specialist service providers. Presented at the Healthcare Europa Annual Conference 2013, New Models for Challenging Times.
The majority of shares in Medicover - the East European healthcare group that owns lab chain Synevo - have been put into a charitable trust: the Jonas and Christina af Jochnick Foundation. Jonas af Jochnick, 75, is a kind of Swedish Bill Gates. What does this mean for the future of the group?
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
